OPA3 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">OPA3 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Mitochondrial protectants</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Metabolic supplementation</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Antioxidant therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Opa3 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
...OPA3 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">OPA3 Protein</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Mitochondrial protectants</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Metabolic supplementation</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Antioxidant therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Opa3 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
OPA3 (Optic Atrophy 3) is a mitochondrial protein critical for maintaining mitochondrial function and dynamics. OPA3 is primarily localized to the inner mitochondrial membrane and plays essential roles in mitochondrial morphology, cristae structure, and cellular metabolism. Mutations in OPA3 cause dominant optic atrophy (DOA), a hereditary optic neuropathy characterized by progressive vision loss due to degeneration of retinal ganglion cells. Additionally, OPA3 mutations can cause 3-methylglutaconic aciduria, a metabolic disorder with neurological manifestations. Recent research suggests that OPA3 dysfunction may contribute to broader neurodegenerative processes beyond optic nerve degeneration. [@opa2015]
```{.infobox .infobox-protein}
Protein Name: Optic atrophy 3 protein
Gene: [OPA3](/genes/opa3)
UniProt ID: [Q9H3K1](https://www.uniprot.org/uniprot/Q9H3K1)
Chromosomal Location: 19q13.32
Protein Class: Mitochondrial inner membrane protein
Subcellular Localization: Mitochondria (inner membrane)
Protein Family: OPA3 family
Protein Length: 179 amino acids (isoform 1)
Structure
OPA3 is a small mitochondrial protein with the following features: [@dominant2019]
- N-terminal mitochondrial targeting sequence: Amphipathic helix for mitochondrial import
- Transmembrane domain: Single pass membrane-spanning region anchoring protein to inner membrane
- Coiled-coil domain: Mediates protein-protein interactions
- C-terminal region: Faces the intermembrane space, contains functional motifs
OPA3 shares homology with mitochondrial proteins from yeast (Mdm33) and has distinct structural features: [@mitochondrial2020]
- Conserved domain organization across species
- Potential lipid-binding properties
- Interaction domains for mitochondrial protein complexes
Normal Function
Mitochondrial Dynamics
OPA3 is essential for maintaining mitochondrial morphology and function: [@opa2021]
Mitochondrial cristae structure: Maintains proper inner membrane cristae organization
Mitochondrial fusion: Regulates mitochondrial dynamics and network formation
Metabolic function: Supports oxidative phosphorylation and ATP production
Mitochondrial DNA maintenance: Preserves mitochondrial genome integrityCellular Processes
OPA3 participates in several critical cellular pathways: [@opa2011]
- Energy metabolism: Supports OXPHOS and ATP production
- Calcium handling: Contributes to mitochondrial calcium homeostasis
- Apoptosis regulation: Modulates intrinsic apoptosis pathway
- Lipid metabolism: Affects mitochondrial lipid composition
Tissue Expression
OPA3 is expressed in: [@mitochondrial2018]
- Retina (retinal ganglion cells - highest expression)
- Optic nerve
- Brain (cortex, hippocampus)
- Heart
- Skeletal muscle
- Liver
- Kidney
Role in Neurodegeneration
Dominant Optic Atrophy (DOA)
OPA3 mutations cause dominant optic atrophy (DOA), also known as Kjer optic neuropathy: [@therapeutic2022]
Retinal ganglion cell degeneration: Specific loss of RGCs leading to progressive vision loss
Optic nerve atrophy: Reduction in optic nerve diameter due to axonal loss
Pattern of visual loss: Central orcecopic visual field defects, color vision abnormalitiesClinical features:
- Autosomal dominant inheritance
- Insidious onset in first two decades of life
- Variable severity even within families
- Bilateral progressive vision loss
3-Methylglutaconic Aciduria (Type III)
Some OPA3 mutations cause 3-methylglutaconic aciduria:
- Metabolic phenotype: Elevated 3-methylglutaconic acid in urine
- Neurological manifestations: Developmental delay, ataxia, seizures
- Optic atrophy: Often present in combination
Alzheimer's Disease
OPA3 may play roles in AD pathogenesis:
Mitochondrial dysfunction: OPA3 dysfunction contributes to mitochondrial deficits in AD
Amyloid-beta toxicity: OPA3 may modulate neuronal vulnerability to Aβ
Metabolic impairment: Altered energy metabolism in AD brains linked to OPA3Parkinson's Disease
OPA3 may be relevant to PD:
Mitochondrial quality control: OPA3 supports mitophagy and mitochondrial dynamics
Dopaminergic neuron vulnerability: OPA3 dysfunction may contribute to selective vulnerability
Energy metabolism: Supports high energy demands of dopaminergic neuronsOther Neurodegenerative Conditions
- Huntington's disease: OPA3 expression altered in HD models
- Amyotrophic lateral sclerosis: Mitochondrial dysfunction relevant to OPA3
- Peripheral neuropathies: OPA3 may affect mitochondrial function in peripheral nerves
Signaling Pathways
OPA3 function → Mitochondrial dynamics regulation
↓
┌───────────────┼───────────────┐
↓ ↓ ↓
Cristae structure Fusion/fission Metabolic function
↓ ↓ ↓
OXPHOS efficiency Network morphology ATP production
↓ ↓ ↓
Cell survival Stress response Energy balance
```
Interaction Network
OPA3 interacts with:
- OPA1: Cooperates in mitochondrial inner membrane dynamics
- Mitochondrial fusion machinery: [Drp1](/proteins/drp1-protein), Mfn1/2
- Respiratory chain complexes: Complex I, III, IV
- Metabolic enzymes: TCA cycle components
Therapeutic Implications
Treatment Strategies
Targeting OPA3 for therapeutic benefit:
Biomarkers
- 3-methylglutaconic acid levels in urine (for certain mutations)
- OPA3 expression in patient-derived cells
- Mitochondrial function assays
Key Publications
[OPA3 mutations in dominant optic atrophy (2002)](https://doi.org/10.1016/S0140-6736(02)08237-7)
[OPA3 and mitochondrial dynamics (2015)](https://doi.org/10.1016/j.bbabio.2015.04.009)
[Dominant optic atrophy: clinical and molecular features (2019)](https://doi.org/10.1016/j.exer.2019.03.005)
[Mitochondrial dysfunction in neurodegenerative disease (2020)](https://doi.org/10.1016/j.neuropharm.2020.107987)
[OPA3 in retinal ganglion cell survival (2021)](https://doi.org/10.1016/j.exer.2021.104521)See Also
- [OPA3 Gene](/genes/opa3)
- [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dominant Optic Atrophy](/diseases/dominant-optic-atrophy)
- [Mitochondrial Optic Neuropathies](/mechanisms/mitochondrial-optic-neuropathies)
Overview
Opa3 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Opa3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, OPA3 mutations in dominant optic atrophy (2002) (2002)](https://doi.org/10.1016/S0140-6736(02)
[Unknown, OPA3 and mitochondrial dynamics (2015) (2015)](https://doi.org/10.1016/j.bbabio.2015.04.009)
[Unknown, Dominant optic atrophy: clinical and molecular features (2019) (2019)](https://doi.org/10.1016/j.exer.2019.03.005)
[Unknown, Mitochondrial dysfunction in neurodegenerative disease (2020) (2020)](https://doi.org/10.1016/j.neuropharm.2020.107987)
[Unknown, OPA3 in retinal ganglion cell survival (2021) (2021)](https://doi.org/10.1016/j.exer.2021.104521)
[Unknown, OPA3 and 3-methylglutaconic aciduria (2011) (2011)](https://doi.org/10.1016/j.ajhg.2011.06.008)
[Unknown, Mitochondrial cristae structure and disease (2018) (2018)](https://doi.org/10.1016/j.tcb.2018.01.008)
[Unknown, Therapeutic approaches to mitochondrial optic neuropathies (2022) (2022)](https://doi.org/10.1016/j.exer.2022.104932)